GHRP (Europeptides)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameGHRP (Europeptides)
Drug Alias NameGHRP (Zentaris/Tulane)growth hormone releasing peptide (Europeptides)GHRP
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGrowth hormone-releasing hormone receptor agonists
TargetsGrowth hormone-releasing hormone receptor
Therapy Area/IndicationsCachexiaGrowth DisordersMetabolic Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTulane University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEuropeptides SACOSCIENS Biopharma Inc
Active IndicationsN/A
Inactive IndicationsCachexiaGrowth DisordersMetabolic Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A